Gemstone Equity Research is bullish on Biocon with a price target of Rs 352 per share.
Most brokerages have cut their earnings estimates to factor in chip shortage impact
Major sectoral indices on the NSE were trading in the red with the Nifty Metal index tanking 1.84%.